Veon (VEON) Operating Expenses (2009 - 2026)

Veon (VEON) has reported Operating Expenses for 17 consecutive years, with $71.5 billion the latest figure, recorded in Q1 2026.

• Operating Expenses for Q1 2026 came in at $71.5 billion, up 14.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.5 billion (up 117.21% YoY), and the FY2025 annual result was $2.5 billion, up 5.71% from the prior year.
• Operating Expenses was $71.5 billion for Q1 2026 at Veon, up from -$606.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $71.5 billion in Q1 2026 and troughed at -$1.1 billion in Q4 2022.
• Average Operating Expenses over 5 years is $16.3 billion, with a median of -$550.0 million recorded in 2023.
• Year-over-year, Operating Expenses jumped 48.25% in 2022 and decreased 9.92% in 2024.
• Over 5 years, Operating Expenses stood at -$1.1 billion in 2022, then jumped by 50.71% to -$524.0 million in 2023, then retreated by 9.92% to -$576.0 million in 2024, then declined by 5.21% to -$606.0 million in 2025, then soared by 11898.35% to $71.5 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $71.5 billion in Q1 2026, -$606.0 million in Q2 2025, and $62.6 billion in Q1 2025.